IRVINE, Calif., Aug. 3, 2015 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, is scheduled to
present at the Canaccord Genuity 35th Annual
Growth Conference at the InterContinental Boston on Wednesday, August 12, 2015.
Donald E. Bobo, Jr., CVP, Heart
Valve Therapy, Strategy and Corporate Development, is scheduled to
speak to conference attendees at 10:00 a.m.
EDT. A live webcast of the presentation will be available to
all interested parties on the Edwards Lifesciences investor
relations website at http://ir.edwards.com/events.cfm.
Following the presentation, an archived version of the
webcast will be available on the Edwards investor relations website
in the News and Events section, and via the Edwards Lifesciences
Investor Relations App for mobile devices.
About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of
heart valves and hemodynamic monitoring. Driven by a passion
to help patients, the company partners with clinicians to develop
innovative technologies in the areas of structural heart disease
and critical care monitoring that enable them to save and enhance
lives. Additional company information can be found at
www.edwards.com.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation.
Logo - http://photos.prnewswire.com/prnh/20140714/126903
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-canaccord-genuity-annual-growth-conference-300122050.html
SOURCE Edwards Lifesciences Corporation